Business Wire

Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of data from a single center, real-world study with one-year clinical follow-up of patients selected from the ...
Business Wire

Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the ...
Healio

Mainstay Medical launches limited commercial release of neurostimulation system in US

Please provide your email address to receive an email when new articles are posted on . Dublin-based Mainstay Medical announced the launch of its product ReActiv8 in the U.S. in limited commercial ...